FDMT CLO exercises options, sells 9,810 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
4D Molecular Therapeutics Chief Legal Officer Scott Bizily reported an exercise-and-sell stock transaction. On June 23, 2026, he exercised options to acquire 9,810 shares of common stock at $4.14 per share, then sold 9,810 shares in an open-market trade at $12.00 per share.
After these transactions, he holds 8,617 common shares directly and 63,785 stock options with a $4.14 exercise price expiring in 2035. A footnote also notes 5,023 shares previously purchased under the company’s Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 9,810 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,810 | $4.14 | $41K |
| Sale | Common Stock | 9,810 | $12.00 | $118K |
Footnotes (2)
- F1. Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
- F2. The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Key Figures
Key Terms
Employee Stock Purchase Plan financial
Rule 16b-3 regulatory
Stock Option (Right to Buy) financial
Vesting Commencement Date financial
derivative exercise/conversion financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did FDMT’s Chief Legal Officer report on June 23, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.